source
- ADC biotech Ona Therapeutics secures $86.6M in Series B raiseBarcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic. CEO Valerie Vanhooren told Endpoints News in an interview that the cash…Endpoints · 1mo ago↗ source
- Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D dealAlnylam Pharmaceuticals announced its first discovery-focused AI deal Wednesday, tapping a Silicon Valley biotech startup to see if AI can boost its R&D efforts. Alnylam and Inceptive signed a coll…Endpoints · 1mo ago↗ source
- Bristol Myers turns focus to AI costs after broad rollout to workersPALO ALTO, CA — After giving artificial intelligence tools to thousands of employees, Bristol Myers Squibb is now working to get a handle on the costs of the technology and where it’s actually crea…